UROLOGIX INC (ULGX)

Overview Price 1.03 Price Change Today -$0.04 (-3.74%) P&P rating Zacks Rank N/A - N/A Open Price $1.10 Previous Close $1.07 Daily Range $1.00 - $1.12 52-Week Range $0.65 - $1.71 Volume 8,749 Urologix, Inc., based in Minneapolis, develops, manufactures and markets minimally invasive medical products for the treatment of urological disorders. The Company has developed and offers non-surgical, anesthesia-free, catheter-based treatments that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia, a condition that affects more than twenty three million men worldwide. Urologix' products include the CoolWave, Targis and Prostatron control units and the Cooled ThermoCath, Targis and Prostaprobe catheter families. Additionally, Urologix is currently developing CoolMax, its next generation microwave catheter for in-office benign prostatic hyperplasia treatment. All of Urologix' products utilize Cooled ThermoTherapy targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort and provide safe, effective, lasting relief of the symptoms of benign prostatic hyperplasia. Other Resources for ULGX Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary No Commentary Found for This Ticker. Urologix, Inc., based in Minneapolis, develops, manufactures and markets minimally invasive medical products for the treatment of urological disorders. The Company has developed and offers non-surgical, anesthesia-free, catheter-based treatments that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia, a condition that affects more than twenty three million men worldwide. Urologix' products include the CoolWave, Targis and Prostatron control units and the Cooled ThermoCath, Targis and Prostaprobe catheter families. Additionally, Urologix is currently developing CoolMax, its next generation microwave catheter for in-office benign prostatic hyperplasia treatment. All of Urologix' products utilize Cooled ThermoTherapy targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort and provide safe, effective, lasting relief of the symptoms of benign prostatic hyperplasia.   Brokerage Analyst Recommendations 1 Brokerage Firms Covering ULGX   Strong Buy 0 Buy 0 Hold 1 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 3   ULGX Ratings: BUY  SELL  HOLD ULGX Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 4 Buy 0 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

No related Blog Posts.

Commentary

BUY: UROLOGIX INC. (ULGX) Start Price: $2.63 Points: -50.61 Created: 01/01/2008 Comments: 0 | Comment rlenz Recs:

BUY: UROLOGIX INC. (ULGX) Start Price: $3.80 Points: -62.67 Created: 01/01/2008 Comments: 0 | Comment dinker Recs:

BUY: UROLOGIX INC. (ULGX) Start Price: $4.05 Points: -64.34 Created: 01/01/2008 Comments: 0 | Comment realizedgain Recs:

BUY: UROLOGIX INC. (ULGX) Start Price: $2.98 Points: -55.21 Created: 01/01/2008 Comments: 0 | Comment shadowfax12 Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
rlenz	31.54	BUY	Six Months to a Year	01/01/2008	$2.63	$1.03 (-1.90%)	-60.84%	-10.23%	-50.61
dinker	10.63	BUY	Six Months to a Year	01/01/2008	$3.80	$1.03 (-1.90%)	-72.90%	-10.23%	-62.67
realizedgain	58.28	BUY	Six Months to a Year	01/01/2008	$4.05	$1.03 (-1.90%)	-74.57%	-10.23%	-64.34
shadowfax12	37.58	BUY	Six Months to a Year	01/01/2008	$2.98	$1.03 (-1.90%)	-65.44%	-10.23%	-55.21